SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Botanical guide · Ingredient reference

    Ashwagandha and memory: a pilot measured short-term test scores

    An eight-week trial found improvements on cognitive tests in adults with mild cognitive impairment. It did not establish prevention of dementia or lasting functional benefit.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026 · Updated October 28, 2026

    What was compared

    Fifty adults with mild cognitive impairment were randomized to a root extract or placebo for eight weeks. The study measured immediate and general memory as well as executive function, attention and processing speed. [1]

    Several test scores improved more in the extract group. This is a signal from a small clinical population, not evidence that every healthy person will gain the same benefit. [1]

    Limits of the result

    The trial did not measure progression to dementia over years. Multiple test outcomes and a short follow-up also require care when judging reproducibility and practical importance. Funding and conflicts were not established from the retrieved abstract. [1]

    A hypothetical distinction

    Imagine an intervention improves a test at eight weeks. Whether people manage daily tasks better or develop less disease years later would require those outcomes to be measured separately.

    Evidence summary — Ashwagandha and memory
    DetailInterpretation
    50 adultsSmall trial
    Eight weeksShort-term testing
    Dementia preventionNot established

    Does this trial establish a treatment for brain fog?

    “Brain fog” is a nonspecific description, not the same enrollment criterion as mild cognitive impairment in this pilot. The study assessed defined memory, attention and processing tests. An improvement on those tests does not establish benefit for every cause of feeling mentally slowed, forgetful or unable to concentrate. [1]

    The short study also cannot establish lasting daily-function improvement or identify the cause of a new symptom. Persistent or worsening cognitive symptoms deserve assessment rather than assuming that an extract tested in one selected group addresses the underlying problem. The trial provides a limited research signal, not a general brain-fog treatment claim. [1]

    Ashwagandha and memory: a pilot measured short-term test scores — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions - PubMed
      Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.